Opus Point Partners Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $973K | Buy |
9,933
+6
| +0.1% | +$588 | 1.76% | 10 |
|
|
2019
Q2 | $1.3M | Hold |
9,927
| – | – | 1.92% | 7 |
|
|
2019
Q1 | $1.34M | Sell |
9,927
-560
| -5% | -$75.7K | 1.82% | 9 |
|
|
2018
Q4 | $1.02M | Sell |
10,487
-2,360
| -18% | -$230K | 2.25% | 11 |
|
|
2018
Q3 | $1.79M | Sell |
12,847
-887
| -6% | -$123K | 4.26% | 6 |
|
|
2018
Q2 | $1.71M | Sell |
13,734
-119
| -0.9% | -$14.8K | 3.7% | 5 |
|
|
2018
Q1 | $1.54M | Buy |
13,853
+4,295
| +45% | +$479K | 3.03% | 7 |
|
|
2017
Q4 | $1.14M | Sell |
9,558
-1,889
| -17% | -$226K | 0.99% | 27 |
|
|
2017
Q3 | $1.61M | Buy |
11,447
+1,921
| +20% | +$270K | 1.44% | 26 |
|
|
2017
Q2 | $1.16M | Sell |
9,526
-9,175
| -49% | -$1.12M | 1.06% | 28 |
|
|
2017
Q1 | $2.27M | Sell |
18,701
-6,272
| -25% | -$760K | 1.68% | 26 |
|
|
2016
Q4 | $3.06M | Buy |
24,973
+402
| +2% | +$49.2K | 2.43% | 16 |
|
|
2016
Q3 | $3.01M | Buy |
24,571
+7,270
| +42% | +$891K | 1.69% | 19 |
|
|
2016
Q2 | $2.02M | Sell |
17,301
-8,104
| -32% | -$946K | 1.95% | 24 |
|
|
2016
Q1 | $3.54M | Sell |
25,405
-7,564
| -23% | -$1.05M | 2.73% | 12 |
|
|
2015
Q4 | $6.29M | Sell |
32,969
-52
| -0.2% | -$9.92K | 4.15% | 4 |
|
|
2015
Q3 | $5.16M | Buy |
33,021
+11,547
| +54% | +$1.81M | 2.85% | 4 |
|
|
2015
Q2 | $3.88M | Sell |
21,474
-557
| -3% | -$101K | 3.07% | 17 |
|
|
2015
Q1 | $3.82M | Buy |
22,031
+3,699
| +20% | +$641K | 3.2% | 15 |
|
|
2014
Q4 | $3.39M | Buy |
+18,332
| New | +$3.39M | 3.36% | 10 |
|